Sick populations and sick subpopulations

Circulation

Volumn 134, Issue 6, 2016, Pages 472-485

  Lu, Yuan ^a   Ezzati, Majid ^b   Rimm, Eric B ^c,d   Hajifathalian, Kaveh ^e   Ueda, Peter ^d   Danaei, Goodarz ^d  

^a YALE NEW HAVEN HOSPITAL   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

Author keywords

cardiovascular diseases; health status disparities; prevention and control; risk; risk factors

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ARTICLE; BLACK PERSON; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; HEALTH DISPARITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; POPULATION RESEARCH; PRIORITY JOURNAL; RACE; SEX; SMOKING; SYSTOLIC BLOOD PRESSURE; TOBACCO; UNITED STATES; CARDIOVASCULAR DISEASES; EPIDEMIOLOGY; HEALTH CARE DISPARITY; HEALTH SURVEY; MIDDLE AGED; MORTALITY; NUTRITION; PROCEDURES; TRENDS;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; CARDIOVASCULAR DISEASES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTHCARE DISPARITIES; HUMANS; MALE; MIDDLE AGED; MORTALITY; NUTRITION SURVEYS; POPULATION SURVEILLANCE; UNITED STATES;

EID: 84976407301     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.018102     Document Type: Article

References (53)

1. Cooper R, Cutler J, Desvigne-Nickens P, Fortmann SP, Friedman L, Havlik R, Hogelin G, Marler J, McGovern P, Morosco G, Mosca L, Pearson T, Stamler J, Stryer D, Thom T. Trends, and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the National Conference on Cardiovascular Disease Prevention. Circulation. 2000; 102: 3137-3147.
2. Harper S, Rushani D, Kaufman JS. Trends in the black-white life expectancy gap, 2003-2008. JAMA. 2012; 307: 2257-2259. doi: 10.1001/jama.2012.5059.
3. Danaei G, Rimm EB, Oza S, Kulkarni SC, Murray CJ, Ezzati M. The promise of prevention: the effects of four preventable risk factors on National life expectancy, and life expectancy disparities by race, and county in the United States. PLoS Med. 2010; 7: e1000248. doi: 10.1371/journal.pmed.1000248.
4. Hozawa A, Folsom AR, Sharrett AR, Chambless LE. Absolute, and attributable risks of cardiovascular disease incidence in relation to optimal, and borderline risk factors: comparison of African American with white subjects: Atherosclerosis Risk in Communities Study. Arch Intern Med. 2007; 167: 573-579. doi: 10.1001/.archinte.167.6.573.
5. Rose G. Sick individuals, and sick populations. Int J Epidemiol. 1985; 14: 32-38.
6. Di Cesare M, Khang YH, Asaria P, Blakely T, Cowan MJ, Farzadfar F, Guerrero R, Ikeda N, Kyobutungi C, Msyamboza KP, Oum S, Lynch JW, Marmot MG, Ezzati M. Lancet NCD Action Group. Inequalities in non-communicable diseases, and effective responses. Lancet. 2013; 381: 585-597. doi: 10.1016/S0140-6736(12)61851-0.
7. Lorenc T, Petticrew M, Welch V, Tugwell P. What types of interventions generate inequalities? Evidence from systematic reviews. J Epidemiol Community Health. 2013; 67: 190-193. doi: 10.1136/.jech-2012-201257.
8. Durkin S, Brennan E, Wakefield M. Mass media campaigns to promote smoking cessation among adults: an integrative review. Tob Control. 2012; 21: 127-138. doi: 10.1136/tobaccocontrol-2011-050345.
9. Bajekal M, Scholes S, Love H, Hawkins N, O Flaherty M, Raine R, Capewell S. Analysing recent socioeconomic trends in coronary heart disease mortality in England, 2000-2007: a population modelling study. PLoS Med. 2012; 9: e1001237.
10. Capewell S, Graham H. Will cardiovascular disease prevention widen health inequalities? PLoS Med. 2010; 7: e1000320. doi: 10.1371/journal.pmed.1000320.
11. Kivimäki M, Shipley MJ, Ferrie JE, Singh-Manoux A, Batty GD, Chandola T, Marmot MG, Smith GD. Best-practice interventions to reduce socioeconomic inequalities of coronary heart disease mortality in UK: a prospective occupational cohort study. Lancet. 2008; 372: 1648-1654. doi: 10.1016/S0140-6736(08)61688-8.
12. McLaren L, McIntyre L, Kirkpatrick S. Rose s population strategy of prevention need not increase social inequalities in health. Int J Epidemiol. 2010; 39: 372-377. doi: 10.1093/ije/dyp315.
13. Khang YH, Lynch JW, Yun S, Lee SI. Trends in socioeconomic health inequalities in Korea: use of mortality, and morbidity measures. J Epidemiol Community Health. 2004; 58: 308-314.
14. Jha P, Peto R, Zatonski W, Boreham J, Jarvis MJ, Lopez AD. Social inequalities in male mortality, and in male mortality from smoking: indirect estimation from National death rates in England, and Wales, Poland, and North America. Lancet. 2006; 368: 367-370. doi: 10.1016/S0140-6736(06)68975-7.
15. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW, Eddleman KM, Jarrett NM, LaBresh K, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/.American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 129(suppl 2): S1-45. doi: 10.1161/01. cir.0000437738.63853.7a.
16. National Cholesterol Education Program Expert Panel on Detection Evaluation Treatment of High Blood Cholesterol in Adults. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002; 106: 3143-3421.
17. He FJ, Pombo-Rodrigues S, Macgregor GA. Salt reduction in England from 2003 to 2011: its relationship to blood pressure, stroke, and ischaemic heart disease mortality. BMJ Open. 2014; 4: e004549.
18. Mozaffarian D, Fahimi S, Singh GM, Micha R, Khatibzadeh S, Engell RE, Lim S, Danaei G, Ezzati M, Powles J. Global Burden of Diseases Nutrition, and Chronic Diseases Expert Group. Global sodium consumption, and death from cardiovascular causes. N Engl J Med. 2014; 371: 624-634. doi: 10.1056/NEJMoa1304127.
19. Puska P, Ståhl T. Health in all policies: the Finnish initiative: background, principles, and current issues. Annu Rev Public Health. 2010; 31: 315-328, 3 p following 328. doi: 10.1146/annurev. publhealth.012809.103658.
20. Jackson R, Beaglehole R. Trends in dietary fat, and cigarette smoking, and the decline in coronary heart disease in New Zealand. Int J Epidemiol. 1987; 16: 377-382.
21. Levy DT, Ellis JA, Mays D, Huang AT. Smoking-related deaths averted due to three years of policy progress. Bull World Health Organ. 2013; 91: 509-518. doi: 10.2471/BLT.12.113878.
22. Colchero MA, Popkin BM, Rivera JA, Ng SW. Beverage purchases from stores in Mexico under the excise tax on sugar sweetened beverages: observational study. BMJ. 2016; 352: h6704.
23. Singh GM, Micha R, Khatibzadeh S, Shi P, Lim S, Andrews KG, Engell RE, Ezzati M, Mozaffarian D. Global Burden of Diseases Nutrition, and Chronic Diseases Expert Group (NutriCoDE). Global, regional, and National consumption of sugar-sweetened beverages, fruit juices, and milk: a systematic assessment of beverage intake in 187 countries. PLoS One. 2015; 10: e0124845. doi: 10.1371/.journal.pone.0124845.
24. Malik VS, Popkin BM, Bray GA, Després JP, Willett WC, Hu FB. Sugar-sweetened beverages, and risk of metabolic syndrome, and type 2 diabetes: a meta-Analysis. Diabetes Care. 2010; 33: 2477-2483. doi: 10.2337/dc10-1079.
25. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E. 2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014; 311: 507-520. doi: 10.1001/.jama.2013.284427.
26. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-Analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009; 338: b1665.
27. Stead LF, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2005; 2: CD001007.
28. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346: 393-403. doi: 10.1056/NEJMoa012512.
29. Hajifathalian K, Ueda P, Lu Y, Woodward M, Ahmadvand A, Aguilar-Salinas CA, Azizi F, Cifkova R, Di Cesare M, Eriksen L, Farzadfar F, Ikeda N, Khalili D, Khang YH, Lanska V, León-Muñoz L, Magliano D, Msyamboza KP, Oh K, Rodríguez-Artalejo F, Rojas-Martinez R, Shaw JE, Stevens GA, Tolstrup J, Zhou B, Salomon JA, Ezzati M, Danaei G. A novel risk score to predict cardiovascular disease risk in National populations (Globorisk): a pooled analysis of prospective cohorts, and health examination surveys. Lancet Diabetes Endocrinol. 2015; 3: 339-355. doi: 10.1016/S2213-8587(15)00081-9.
30. Liao Y, McGee DL, Cooper RS. Prediction of coronary heart disease mortality in blacks, and whites: pooled data from two National cohorts. Am J Cardiol. 1999; 84: 31-36.
31. Keil JE, Sutherland SE, Knapp RG, Lackland DT, Gazes PC, Tyroler HA. Mortality rates, and risk factors for coronary disease in black as compared with white men, and women. N Engl J Med. 1993; 329: 73-78. doi: 10.1056/NEJM199307083290201.
32. Mitchell BD, Haffner SM, Hazuda HP, Patterson JK, Stern MP. Diabetes, and coronary heart disease risk in Mexican Americans. Ann Epidemiol. 1992; 2: 101-106.
33. McNeill AM, Rosamond WD, Girman CJ, Golden SH, Schmidt MI, East HE, Ballantyne CM, Heiss G. The metabolic syndrome, and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities Study. Diabetes Care. 2005; 28: 385-390.
34. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review, and meta-Analysis. BMJ. 2003; 326: 1423. doi: 10.1136/bmj.326.7404.1423.
35. Singh GM, Danaei G, Farzadfar F, Stevens GA, Woodward M, Wormser D, Kaptoge S, Whitlock G, Qiao Q, Lewington S, Di Angelantonio E, Vander Hoorn S, Lawes CM, Ali MK, Mozaffarian D, Ezzati M. The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases, and diabetes: a pooled analysis. PLoS One. 2013; 8: e65174.
36. Prospective Studies Collaboration, Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R. Blood cholesterol, and vascular mortality by age, sex, and blood pressure: a meta-Analysis of individual data from 61 prospective studies with 55, 000 vascular deaths. Lancet. 2007; 370: 1829-1839.
37. Lawes CM, Bennett DA, Parag V, Woodward M, Whitlock G, Lam TH, Suh I, Rodgers A. Asia Pacific Cohort Studies Collaboration. Blood pressure indices, and cardiovascular disease in the Asia Pacific region: a pooled analysis. Hypertension. 2003; 42: 69-75. doi: 10.1161/01.HYP.0000075083.04415.4B.
38. Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review, and meta-Analysis of prospective cohort studies. Lancet. 2011; 378: 1297-1305. doi: 10.1016/S0140-6736(11)60781-2.
39. Peters SA, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review, and meta-Analysis of 64 cohorts, including 775, 385 individuals, and 12, 539 strokes. Lancet. 2014; 383: 1973-1980. doi: 10.1016/.S0140-6736(14)60040-4.
40. Safford MM, Brown TM, Muntner PM, Durant RW, Glasser S, Halanych JH, Shikany JM, Prineas RJ, Samdarshi T, Bittner VA, Lewis CE, Gamboa C, Cushman M, Howard V, Howard G. REGARDS Investigators. Association of race, and sex with risk of incident acute coronary heart disease events. JAMA. 2012; 308: 1768-1774. doi: 10.1001/jama.2012.14306.
41. Howard VJ, Kleindorfer DO, Judd SE, McClure LA, Safford MM, Rhodes JD, Cushman M, Moy CS, Soliman EZ, Kissela BM, Howard G. Disparities in stroke incidence contributing to disparities in stroke mortality. Ann Neurol. 2011; 69: 619-627. doi: 10.1002/.ana.22385.
42. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PW, Jordan HS, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/.American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 129(suppl 2): S49-S73. doi: 10.1161/01. cir.0000437741.48606.98.
43. Manuel DG, Lim J, Tanuseputro P, Anderson GM, Alter DA, Laupacis A, Mustard CA. Revisiting Rose: strategies for reducing coronary heart disease. BMJ. 2006; 332: 659-662. doi: 10.1136/.bmj.332.7542.659.
44. Morrow DA. Cardiovascular risk prediction in patients with stable, and unstable coronary heart disease. Circulation. 2010; 121: 2681-2691. doi: 10.1161/CIRCULATIONAHA.109.852749.
45. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, Mautner B, Corbalan R, Radley D, Braunwald E. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication, and therapeutic decision making. JAMA. 2000; 284: 835-842.
46. Mann DM, Woodward M, Muntner P, Falzon L, Kronish I. Predictors of nonadherence to statins: a systematic review, and meta-Analysis. Ann Pharmacother. 2010; 44: 1410-1421. doi: 10.1345/.aph.1P150.
47. Walker EA, Molitch M, Kramer MK, Kahn S, Ma Y, Edelstein S, Smith K, Johnson MK, Kitabchi A, Crandall J. Adherence to preventive medications: predictors, and outcomes in the Diabetes Prevention Program. Diabetes Care. 2006; 29: 1997-2002. doi: 10.2337/dc06-0454.
48. Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, Wilson K, Buchan I, Gill CJ, Cooper C. Adherence to HAART: a systematic review of developed, and developing nation patientreported barriers, and facilitators. PLoS Med. 2006; 3: e438. doi: 10.1371/journal.pmed.0030438.
49. US Department of Health Human Services. Healthy People 2020. https://www.healthypeople.gov/2020/about/foundation-healthmeasures/.Disparities. 2011. Accessed December 30, 2015.
50. McWilliams JM, Meara E, Zaslavsky AM, Ayanian JZ. Differences in control of cardiovascular disease, and diabetes by race, ethnicity, and education: U.S. trends from 1999 to 2006, and effects of Medicare coverage. Ann Intern Med. 2009; 150: 505-515.
51. Farzadfar F, Murray CJ, Gakidou E, Bossert T, Namdaritabar H, Alikhani S, Moradi G, Delavari A, Jamshidi H, Ezzati M. Effectiveness of diabetes, and hypertension management by rural primary health-care workers (Behvarz workers) in Iran: a Nationally representative observational study. Lancet. 2012; 379: 47-54. doi: 10.1016/S0140-6736(11)61349-4.
52. US Department of Health, and Human Services. The Affordable Care Act http://wwwhealthcaregov/law/introduction/indexhtml. 2010. Accessed December 30, 2015.
53. Sommers BD, Gunja MZ, Finegold K, Musco T. Changes in self-reported insurance coverage, access to care, and health under the Affordable Care Act. JAMA. 2015; 314: 366-374. doi: 10.1001/.jama.2015.8421.